- 4.6Impact Factor
- 8.6CiteScore
- 17 daysTime to First Decision
Special Issues
Sensors publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Analysis and Application of Bioactive Compounds in Functional Foods
Deadline: 30 June 2026
Research and Application of Plant Sourced Polysaccharides—3rd Edition
Deadline: 30 June 2026
Chemical Innovations for Cardiovascular Therapeutics
Deadline: 30 June 2026
Topological Polymers for Advanced Materials
Deadline: 30 June 2026
Chemical Composition, Antiradical Potential and Sensory Qualities of Lesser-Known Fruits
Deadline: 30 June 2026
Supramolecular Catalytic Systems Build on Macrocycle-Base Host-Guest Interactions
Deadline: 30 June 2026
Advances in Supramolecular Systems for Biomolecular Recognition
Deadline: 30 June 2026
Design, Synthesis, and Photochemical Studies of Functional Dyes
Deadline: 30 June 2026
Bioactivity of Natural Compounds: From Plants to Humans, 2nd Edition
Deadline: 30 June 2026
New Achievements and Challenges in Food Chemistry, 2nd Edition
Deadline: 30 June 2026
Rational Design, Synthesis, and Evaluation of Small-Molecule Anticancer Agents
Deadline: 30 June 2026
Advances in Molecular Targets and Signaling Pathways for Drug Discovery
Deadline: 30 June 2026
of 352

